11 April 2019: ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics,  was informed on 11 April 2019 that, on the same day, the following purchases of the Company’s ordinary shares of 1p each (“Ordinary Shares”) were made by directors of the Company

Click here for full article…

Back